Dimensional Fund Advisors
ONCT

Dimensional Fund Advisors’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Dimensional Fund Advisors’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-26,298
Closed -$200K – 3432
2024
Q2 		$200K Buy
26,298
+406
+2% +$3.5K ﹤0.01% 3166
2024
Q1 		$233K Buy
+25,892
New +$228K ﹤0.01% 3172
2014
Q4 		– Sell
-8
Closed -$8K – 3528
2014
Q3 		$8K Sell
8
-5
-38% -$7.37K ﹤0.01% 3493
2014
Q2 		$26K Sell
13
-20
-61% -$39.6K ﹤0.01% 3482
2014
Q1 		$70K Sell
33
-95
-74% -$237K ﹤0.01% 3424
2013
Q4 		$295K Sell
128
-27
-17% -$61.8K ﹤0.01% 3242
2013
Q3 		$437K Sell
155
-93
-38% -$463K ﹤0.01% 3209
2013
Q2 		$2.29M Buy
+248
New +$1.91M ﹤0.01% 2785

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PPW
Pasadena Private Wealth Pasadena, California $723M AUM 18.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Dimensional Fund Advisors's ONCT Position: Q3 2024 in Review

Dimensional Fund Advisors sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q3 2024, closing a stake of 26,298 shares — an estimated $200K sold.

Dimensional Fund Advisors first reported a position in ONCT in Q2 2013 and held it in 8 quarters. The position peaked at $2.29M in Q2 2013. 23 funds tracked by Wall St. Rank hold ONCT as of Q3 2024.

  • Dimensional Fund Advisors reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 26,298 Oncternal Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $200K.
  • Dimensional Fund Advisors first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q2 2013 and held it in 8 quarters.
  • Dimensional Fund Advisors's Oncternal Therapeutics, Inc. Common Stock position peaked at $2.29M in Q2 2013.
  • 23 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Dimensional Fund Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.